Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Anolik

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Journal of Rheumatology|April 5, 2011
Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?Jennifer Anolik
Arthritis Research & Therapy|October 7, 2005
Reconstitution of the adult B cell repertoire after treatment with rituximabIñaki Sanz, Jennifer Anolik
Current Opinion in Rheumatology|August 18, 2004
B cells in human and murine systemic lupus erythematosusJennifer Anolik, Iñaki Sanz
Modern Rheumatology|August 12, 2009
A perspective on B-cell-targeting therapy for SLER John Looney, Jennifer Anolik, Inaki Sanz
Rheumatic Diseases Clinics of North America|March 1, 2006
New therapies for systemic lupus erythematosus: cellular targetsR John Looney, Jennifer Anolik, Iñaki Sanz
Current Opinion in Rheumatology|April 23, 2004
B cells as therapeutic targets for rheumatic diseasesR John Looney, Jennifer Anolik, Inãki Sanz
Current Rheumatology Reports|October 5, 2007
Vaccine responses in patients with rheumatoid arthritisRajan Ravikumar, Jennifer Anolik, R John Looney
Current Directions in Autoimmunity|November 27, 2004
Treatment of SLE with anti-CD20 monoclonal antibodyR John Looney, Jennifer Anolik, Iñaki Sanz
Current Rheumatology Reports|September 12, 2003
B cell depletion therapy in systemic lupus erythematosusJennifer Anolik, Iñaki Sanz, R John Looney
Springer Seminars in Immunopathology|January 6, 2005
Human innate B cells: a link between host defense and autoimmunity?Eric C B Milner, Jennifer Anolik, Amedeo Cappione, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Journal of Rheumatology|April 5, 2011
Immunologic reconstitution after rituximab in systemic lupus erythematosus: why should we care?Jennifer Anolik
Arthritis Research & Therapy|October 7, 2005
Reconstitution of the adult B cell repertoire after treatment with rituximabIñaki Sanz, Jennifer Anolik
Current Opinion in Rheumatology|August 18, 2004
B cells in human and murine systemic lupus erythematosusJennifer Anolik, Iñaki Sanz
Modern Rheumatology|August 12, 2009
A perspective on B-cell-targeting therapy for SLER John Looney, Jennifer Anolik, Inaki Sanz
Rheumatic Diseases Clinics of North America|March 1, 2006
New therapies for systemic lupus erythematosus: cellular targetsR John Looney, Jennifer Anolik, Iñaki Sanz
Current Opinion in Rheumatology|April 23, 2004
B cells as therapeutic targets for rheumatic diseasesR John Looney, Jennifer Anolik, Inãki Sanz
Current Rheumatology Reports|October 5, 2007
Vaccine responses in patients with rheumatoid arthritisRajan Ravikumar, Jennifer Anolik, R John Looney
Current Directions in Autoimmunity|November 27, 2004
Treatment of SLE with anti-CD20 monoclonal antibodyR John Looney, Jennifer Anolik, Iñaki Sanz
Current Rheumatology Reports|September 12, 2003
B cell depletion therapy in systemic lupus erythematosusJennifer Anolik, Iñaki Sanz, R John Looney
Springer Seminars in Immunopathology|January 6, 2005
Human innate B cells: a link between host defense and autoimmunity?Eric C B Milner, Jennifer Anolik, Amedeo Cappione, et al.
Pageof 3